IOVA FY 2009 Earnings — Iovance Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

IOVAIovance Biotherapeutics, Inc.

$2B

FY 2009 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$15,772

Net Income

-$15,772

EPS (Diluted)

$-0.02

Cash Flow

Operating Cash Flow

-$14,448

Free Cash Flow

-$14,448

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$9,632

Total Liabilities

$23,120

Stockholders' Equity

-$13,488

Cash & Equivalents

$8,257

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$15,772	-$57,140	+72.4%
Net Income	-$15,772	-$57,140	+72.4%